Organization Overview
Alternative names
abiraterone (zytiga) (1 trial)
acetylsalicylic acid (aspirin) (8 trials)
adefovir dipivoxil (hepsera) (5 trials)
agomelatine (Valdoxan) (1 trial)
allopurinol (zyloprim) (2 trials)
alteplase (Activase) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (5 trials)
arsenic trioxide (trisenox) (4 trials)
atorvastatin (lipitor) (4 trials)
azathioprine (imuran) (8 trials)
bicalutamide (casodex) (5 trials)
bortezomib (velcade) (6 trials)
budesonide (rhinocort) (1 trial)
carboplatin (paraplatin) (65 trials)
celecoxib (celebrex) (8 trials)
cenegermin-bkbj (oxervate) (2 trials)
cisatracurium (nimbex) (1 trial)
cisplatin (platinol) (149 trials)
clarithromycin (biaxin) (3 trials)
clopidogrel (plavix) (2 trials)
cyclophosphamide (cytoxan) (66 trials)
cytarabine (cytosar-u) (11 trials)
dapagliflozin (farxiga) (5 trials)
desmopressin (ddavp) (2 trials)
entecavir (baraclude) (23 trials)
enzalutamide (xtandi) (1 trial)
esketamine (spravato) (2 trials)
esomeprazole (nexium) (4 trials)
estradiol (progynon depot) (3 trials)
etanercept (enbrel) (6 trials)
etoposide (vepesid) (24 trials)
fluorometholone (fml) (1 trial)
formoterol (foradil) (1 trial)
goserelin (zoladex) (3 trials)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
icodextrin (Extraneal) (1 trial)
infliximab (remicade) (6 trials)
insulin aspart (Novolog) (2 trials)
insulin glargine (toujeo) (4 trials)
insulin human (humulin) (12 trials)
insulin lispro (humalog) (4 trials)
interferon alpha-2b (Intron-A) (20 trials)
iodixanol (visipaque) (1 trial)
lamivudine (epivir) (7 trials)
lapatinib (tykerb) (48 trials)
levobupivacaine (chirocaine) (1 trial)
lidocaine (xylocaine) (1 trial)
luspatercept (Reblozyl) (1 trial)
mercaptopurine (purinethol) (4 trials)
metformin (glucophage) (6 trials)
mitoxantrone (novantrone) (7 trials)
montelukast (singulair) (2 trials)
mycophenolate (CellCept) (9 trials)
olaparib (lynparza) (3 trials)
palivizumab (Synagis) (1 trial)
pioglitazone (actos) (3 trials)
pitavastatin (livalo) (1 trial)
prednisone (meticorten) (27 trials)
progesterone (progestasert) (6 trials)
propofol (diprivan) (9 trials)
ranibizumab (lucentis) (8 trials)
rasburicase (Elitek) (1 trial)
remifentanil (ultiva) (4 trials)
rituximab (rituxan) (22 trials)
rivaroxaban (xarelto) (1 trial)
rocuronium (zemuron) (1 trial)
rosuvastatin (crestor) (1 trial)
ruxolitinib (jakafi) (1 trial)
saxagliptin (onglyza) (2 trials)
sevoflurane (ultane) (5 trials)
sildenafil (viagra) (2 trials)
sitagliptin (januvia) (9 trials)
somatropin (protropin) (6 trials)
sorafenib (nexavar) (23 trials)
sulfasalazine (azulfidine) (2 trials)
sulodexide (Aterina) (1 trial)
tacrolimus (prograf) (12 trials)
tamoxifen (nolvadex) (11 trials)
telbivudine (tyzeka) (6 trials)
tenofovir (viread) (10 trials)
terlipressin (Terlivaz) (3 trials)
thalidomide (Thalomid) (9 trials)
thymalfasin (zadaxin) (4 trials)
vancomycin (Vancocin) (1 trial)
vecuronium (norcuron) (1 trial)
vedolizumab (entyvio) (2 trials)
vincristine (oncovin) (21 trials)
131i-lipiodol (Lipiodol) (5 trials)
adalimumab (humira) (3 trials)
alemtuzumab (campath) (1 trial)
allogeneic blood cells (3 trials)
allogeneic mesenchymal stem cells (1 trial)
alprostadil (prostin) (2 trials)
autologous cytokine induced killer cells (3 trials)
autologous mesenchymal stem cells (15 trials)
azacitidine (vidaza) (6 trials)
bevacizumab (avastin) (48 trials)
bleomycin (blenoxane) (3 trials)
bone marrow derived mesenchymal stem cells (5 trials)
busulfan (Myleran) (15 trials)
capecitabine (xeloda) (78 trials)
cd25 monoclonal antibody (1 trial)
cetuximab (erbitux) (15 trials)
cladribine (leustatin) (5 trials)
cord blood hematopoietic stem cell (1 trial)
crizotinib (xalkori) (2 trials)
cyclosporine (sandimmune) (10 trials)
cytokine induced killer cells (4 trials)
dasatinib (sprycel) (2 trials)
decitabine (dacogen) (10 trials)
doxycycline (vibramycin) (5 trials)
dydrogesterone (gynorest) (2 trials)
eltrombopag (promacta) (1 trial)
endostatin (endostar) (11 trials)
epirubicin (ellence) (16 trials)
erlotinib (tarceva) (11 trials)
Filgrastim (neupogen) (14 trials)
fludarabine (fludara) (15 trials)
fluorouracil (efudex) (112 trials)
follitropin alfa (Gonal-F) (1 trial)
fruquintinib (Fruzaqla) (8 trials)
fulvestrant (faslodex) (11 trials)
gefitinib (iressa) (10 trials)
gemcitabine (gemzar) (74 trials)
human choriogonadotropin alfa (hCG) (4 trials)
icosapent ethyl (vascepa) (1 trial)
idarubicin (idamycin) (3 trials)
irinotecan (Camptosar) (40 trials)
levoleucovorin (fusilev) (2 trials)
linaclotide (linzess) (1 trial)
megakaryocytic progenitor cells (1 trial)
melphalan (alkeran) (4 trials)
methylprednisolone (medrol) (10 trials)
mitomycin (mutamycin) (3 trials)
monosialoganglioside (1 trial)
monosialotetrahexosyl ganglioside (4 trials)
moxifloxacin (avelox) (4 trials)
neratinib maleate (nerlynx) (3 trials)
nitric oxide (inomax) (1 trial)
nivolumab (opdivo) (10 trials)
olanzapine (zyprexa) (3 trials)
oprelvekin (Neumega) (1 trial)
osimertinib (tagrisso) (8 trials)
oxaliplatin (eloxatin) (112 trials)
paclitaxel (taxol) (101 trials)
palonosetron (aloxi) (3 trials)
pegaspargase (oncaspar) (12 trials)
pembrolizumab (keytruda) (7 trials)
pemetrexed (alimta) (25 trials)
pertuzumab (perjeta) (7 trials)
pomalidomide (pomalyst) (2 trials)
propranolol (inderal) (1 trial)
recombinant human adenovirus type 5 (1 trial)
Recombinant Human Type-5 Adenovirus (Gendicine) (1 trial)
rifaximin (xifaxan) (3 trials)
sacubitril (Entresto) (1 trial)
sargramostim (leukine) (5 trials)
silver diammine fluoride (1 trial)
sirolimus (rapamune) (1 trial)
temozolomide (temodar) (12 trials)
topotecan (hycamtin) (2 trials)
toremifene (fareston) (2 trials)
toripalimab (LOQTORZ) (61 trials)
tranexamic acid (cyklokapron) (2 trials)
trastuzumab (herceptin) (17 trials)
tremelimumab (Imjudo) (4 trials)
tripterygium wilfordii (1 trial)
triptorelin (Trelstar) (1 trial)
tumor necrosis factor (1 trial)
umbilical cord mesenchymal stem cells (12 trials)
ursodeoxycholic acid (1 trial)
venetoclax (venclexta) (3 trials)
vinorelbine (navelbine) (16 trials)
vortioxetine (trintellix) (1 trial)
1,4-butanethiosulfonate (1 trial)
ademetionine1,4-butanethiosulfonate (1 trial)
albumin (Human) (Plasbumin) (1 trial)
aldesleukin (Proleukin) (6 trials)
allogeneic adipose derived mesenchymal stem cell (2 trials)
allogeneic cord blood (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (5 trials)
allogeneic lymphocytes (1 trial)
allogeneic stem cells (1 trial)
anastrozole (arimidex) (1 trial)
asparaginase (elspar) (3 trials)
atezolizumab (Tecentriq) (4 trials)
autologous dendritic cells (1 trial)
autologous tumor infiltrating lymphocytes (3 trials)
azithromycin (zithromax) (1 trial)
bacillus mesentericus jpc (1 trial)
basiliximab (Simulect) (1 trial)
bendamustine (treanda) (1 trial)
betamethasone (celestone) (1 trial)
bifidobacterium bifidum (1 trial)
binimetinib (mektovi) (1 trial)
bromocriptine (parlodel) (2 trials)
capmatinib (Tabrecta) (1 trial)
chlorotrianisene (tace) (1 trial)
clostridium butyricum (1 trial)
crisaborole (eucrisa) (1 trial)
cyanocobalamin (berocca) (3 trials)
dabrafenib (tafinlar) (1 trial)
dacarbazine (dtic-dome) (1 trial)
dactinomycin (cosmegen) (2 trials)
daunorubicin (cerubidine) (1 trial)
deferoxamine (desferal) (1 trial)
dendritic cell activated cytokine-induced killer cell (1 trial)
desloratadine (clarinex) (1 trial)
donepezil (aricept) (2 trials)
durvalumab (imfinzi) (2 trials)
duvelisib (copiktra) (2 trials)
edaravone (radicava) (3 trials)
Efbemalenograstim alpha (Ryzneuta) (1 trial)
encorafenib (braftovi) (2 trials)
everolimus (zortress) (2 trials)
exemestane (aromasin) (2 trials)
exosomes from mesenchymal stem cells (1 trial)
ferric derisomaltose (Monoferric) (1 trial)
furmonertinib (Ives) (3 trials)
genetically engineered ny-eso-1-specific t lymphocytes (2 trials)
gentamicin (garamycin) (1 trial)
granisetron (kytril) (1 trial)
human fecal microbiota (Reybota) (1 trial)
human placental derived stem cells (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
ibrutinib (imbruvica) (1 trial)
immune globulin (human) (Gamastan) (1 trial)
interferon alpha-2a (roferon-a) (7 trials)
itraconazole (sporanox) (1 trial)
lanreotide (somatuline depot) (1 trial)
lenalidomide (revlimid) (7 trials)
levofloxacin (levaquin) (1 trial)
masct:multiple antigens specific cellular therapy (2 trials)
minocycline (minocin) (3 trials)
mirtazapine (remeron) (1 trial)
multiple sarcoma-specific car-t cells (1 trial)
multiple signals loaded dendritic cells vaccine (1 trial)
naxitamab (Danyelza) (1 trial)
obinutuzumab (gazyva) (1 trial)
pemigatinib (Pemazyre) (2 trials)
potassium chloride (klor-con) (1 trial)
prednisolone (hydeltra) (2 trials)
procaine merethoxylline (1 trial)
scopolamine (transderm scop) (1 trial)
sodium fluoride (18F) (1 trial)
streptococcus faecalis jpc (1 trial)
tipiracil (lonsurf) (3 trials)
tocilizumab (actemra) (1 trial)
trametinib (mekinist) (1 trial)
trifluridine (viroptic) (1 trial)
trilaciclib (Cosela) (2 trials)
trolamine polypeptide oleate condensate (cerumenex) (1 trial)
tumour infiltrating lymphocytes (2 trials)
umbilical mesenchymal stem cells derived exosomes (1 trial)
vemurafenib (zelboraf) (1 trial)
vinblastine (velban) (1 trial)
vindesine (Eldisine) (1 trial)
acetaminophen (tylenol) (1 trial)
allogeneic natural killer cells (1 trial)
chimeric antigen receptor t cells, eps8 or wt1 peptide specific dendritic cell (1 trial)
conbercept (Lumitin) (5 trials)
crispr/cas9 plasmid, c32-447 (1 trial)
cxcr5 modified egfr chimeric antigen receptor autologous t cells (1 trial)
daclatasvir (daklinza) (1 trial)
dendritic cells loaded with 17 antigens (1 trial)
endostatin adenovirus (1 trial)
gpc3 and/or tgfβ targeting car-t cells (1 trial)
indocyanine green (ic-green) (3 trials)
lmp2 antigen-specific tcr t cells (1 trial)
amantadine (symmetrel) (1 trial)
benazepril (lotensin) (1 trial)
brimonidine (alphagan) (1 trial)
brinzolamide (azopt) (1 trial)
carboprost tromethamine (hemabate) (1 trial)
caspofungin (cancidas) (1 trial)
ciprofloxacin (cipro) (1 trial)
clindamycin (cleocin) (1 trial)
dehydroepiandrosterone (1 trial)
desflurane (suprane) (1 trial)
diclofenac (voltaren) (1 trial)
ethambutol (myambutol) (1 trial)
flurbiprofen (ansaid) (2 trials)
ganciclovir (cytovene) (1 trial)
gardenia jasminoides ellis (1 trial)
gatifloxacin (Zymar) (1 trial)
human urinary kallidinogenase (1 trial)
isoniazid (nydrazid) (1 trial)
lactobacillus casei (2 trials)
latanoprost (xalatan) (1 trial)
menopausal gonadotropin (1 trial)
metronidazole (flagyl) (3 trials)
midodrine (proamatine) (1 trial)
nalbuphine (nubain) (2 trials)
norepinephrine (levophed) (2 trials)
omega-3 fatty acids (Omacor) (1 trial)
oxycodone (oxycontin) (1 trial)
oxytocin (syntocinon) (1 trial)
pazopanib (votrient) (1 trial)
peginterferon beta-1a (Plegridy) (1 trial)
pilocarpine (ocusert) (1 trial)
platelet-rich plasma (2 trials)
proparacaine (ophthaine) (3 trials)
rimabotulinumtoxinB (Myobloc) (1 trial)
sieyesbeckiaorientalis (1 trial)
simvastatin (zocor) (3 trials)
sodium picosulfate (Preopik) (1 trial)
tetraprenylacetone (teprenon) (1 trial)
tetrasodium pyrophosphate (1 trial)
triamcinolone (kenalog) (1 trial)
tropicamide (mydriacyl) (1 trial)
upadacitinib (Rinvoq) (1 trial)
vandetanib (caprelsa) (1 trial)
verteporfin (visudyne) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 1)
Acromegaly (Phase 2)
Acute Coronary Syndrome (Phase 4)
Acute Disease (Phase 3)
Acute Lung Injury (Phase 1)
Acute-On-Chronic Liver Failure (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma of Lung (Phase 2)
Adenoviridae Infections (Phase 3)
Albuminuria (Phase 4)
Alzheimer Disease (Phase 2)
Anastomotic Leak (Phase 3)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Aneurysm (Phase 4)
Ankylosis (Phase 3)
Aortic Aneurysm (Phase 4)
Arteriosclerosis (Phase 4)
Arteriosclerosis Obliterans (Phase 4)
Arteriovenous Malformations (Phase 4)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Asthma (Phase 4)
Astrocytoma (Phase 3)
Atrial Fibrillation (Phase 4)
Atrophic Vaginitis (Phase 1)
Atrophy (Phase 1)
Autoimmune Diseases (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Bone Diseases (Phase 3)
Bone Marrow Diseases (Phase 4)
Bone Neoplasms (Phase 4)
Brain Injuries (Phase 2)
Brain Neoplasms (Phase 3)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 4)
Bronchial Neoplasms (Phase 2)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Burns (Phase 3)
Carcinoma (Phase 4)
Carcinoma, Ductal (Phase 3)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 2)
Cardiomyopathies (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Stenosis (Phase 2)
Cerebral Infarction (Phase 2)
Cerebral Small Vessel Diseases (Phase 4)
Cholangiocarcinoma (Phase 3)
Cholestasis (Phase 3)
Choroidal Neovascularization (Phase 4)
Cognitive Dysfunction (Phase 4)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 2)
Conjunctivitis, Allergic (Phase 4)
Constipation (Phase 3)
Constriction, Pathologic (Phase 2)
Corneal Diseases (Phase 2)
Coronavirus Infections (Phase 2)
Crohn Disease (Phase 3)
Cytomegalovirus Infections (Phase 2)
Death (Phase 1)
Delayed Emergence from Anesthesia (Phase 4)
Delirium (Phase 4)
Dental Caries (Phase 3)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Dermatitis (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 4)
Diabetic Retinopathy (Phase 1)
Diarrhea (Phase 2)
Digestive System Neoplasms (Phase 3)
Dilatation, Pathologic (Phase 2)
Disease (Phase 4)
Disseminated Intravascular Coagulation (Phase 3)
Dry Eye Syndromes (Phase 4)
Dwarfism, Pituitary (Phase 4)
Dyslipidemias (Phase 4)
Edema (Phase 2)
Emergence Delirium (Phase 4)
Endocarditis (Phase 4)
Endocrine System Diseases (Phase 4)
Endometrial Neoplasms (Phase 2)
End Stage Liver Disease (Phase 2)
Esophageal and Gastric Varices (Phase 3)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Exophthalmos (Phase 3)
Eye Burns (Phase 3)
Eye Diseases (Phase 3)
Eye Diseases, Hereditary (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Fatty Liver (Phase 4)
Fibrosis (Phase 4)
Fistula (Phase 3)
Gangliosidoses (Phase 3)
Gangliosidosis, GM1 (Phase 3)
Gastroesophageal Reflux (Phase 3)
Gastrointestinal Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 2)
Genetic Diseases, Inborn (Phase 2)
Gestational Trophoblastic Disease (Phase 3)
Glaucoma (Phase 2)
Glaucoma, Neovascular (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Glomerulonephritis (Phase 2)
Glomerulonephritis, IGA (Phase 4)
Glomerulonephritis, Membranous (Phase 2)
Glucose Metabolism Disorders (Phase 4)
Graft vs Host Disease (Phase 4)
Graves Disease (Phase 2)
Graves Ophthalmopathy (Phase 3)
Hand-Foot Syndrome (Phase 4)
Headache (Phase 4)
Head and Neck Neoplasms (Phase 4)
Hemangioma (Phase 1)
Hematologic Diseases (Phase 3)
Hemorrhage (Phase 4)
Hemosiderosis (Phase 1)
Hepatic Insufficiency (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 4)
Hepatorenal Syndrome (Phase 4)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 2)
Hypercalcemia (Phase 2)
Hypercholesterolemia (Phase 1)
Hyperopia (Phase 2)
Hyperparathyroidism (Phase 2)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 3)
Hyperthyroidism (Phase 2)
Hypertriglyceridemia (Phase 4)
Hyperuricemia (Phase 4)
Hypopharyngeal Neoplasms (Phase 3)
Hypothyroidism (Phase 3)
Immune System Diseases (Phase 2)
Infarction (Phase 2)
Infections (Phase 4)
Infertility (Phase 4)
Inflammation (Phase 4)
Insulin Resistance (Phase 4)
Intestinal Neoplasms (Phase 3)
Irritable Bowel Syndrome (Phase 3)
Ischemia (Phase 3)
Keratoconjunctivitis (Phase 4)
Keratoconjunctivitis Sicca (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Neoplasms (Phase 2)
Kidney Tubular Necrosis, Acute (Phase 2)
Leukemia (Phase 4)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 4)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Promyelocytic, Acute (Phase 4)
Lipid Metabolism Disorders (Phase 4)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 4)
Liver Failure (Phase 2)
Liver Neoplasms (Phase 4)
Lung Diseases (Phase 3)
Lung Diseases, Interstitial (Phase 2)
Lung Neoplasms (Phase 4)
Lupus Nephritis (Phase 4)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 2)
Macular Edema (Phase 4)
Malnutrition (Phase 3)
Melanoma (Phase 2)
Mesothelioma (Phase 1)
Metabolic Diseases (Phase 4)
Microsatellite Instability (Phase 1)
Mouth Neoplasms (Phase 3)
Mucositis (Phase 4)
Multiple Myeloma (Phase 4)
Musculoskeletal Diseases (Phase 3)
Myasthenia Gravis (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myocardial Infarction (Phase 2)
Myopia (Phase 2)
Nasal Polyps (Phase 4)
Nasopharyngeal Carcinoma (Phase 4)
Nasopharyngeal Diseases (Phase 3)
Nasopharyngeal Neoplasms (Phase 4)
Nausea (Phase 3)
Necrosis (Phase 4)
Neoplasm Metastasis (Phase 4)
Neoplasm Recurrence, Local (Phase 3)
Neoplasm, Residual (Phase 3)
Neoplasms (Phase 4)
Neoplasms, Experimental (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Glandular and Epithelial (Phase 1)
Neoplasms, Plasma Cell (Phase 4)
Neoplasms, Second Primary (Phase 2)
Neoplasms, Squamous Cell (Phase 3)
Neovascularization, Pathologic (Phase 4)
Nephritis (Phase 4)
Nephrosis (Phase 3)
Nephrotic Syndrome (Phase 3)
Neuralgia (Phase 3)
Neuroblastoma (Phase 2)
Neuromyelitis Optica (Phase 4)
Neurotoxicity Syndromes (Phase 3)
Neutropenia (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 4)
Oligodendroglioma (Phase 3)
Osteosarcoma (Phase 4)
Ovarian Hyperstimulation Syndrome (Phase 4)
Ovarian Neoplasms (Phase 3)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 4)
Penile Neoplasms (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Peritoneal Neoplasms (Phase 3)
Philadelphia Chromosome (Phase 3)
Pneumonia (Phase 2)
Polycystic Ovary Syndrome (Phase 4)
Postoperative Complications (Phase 4)
Prediabetic State (Phase 4)
Preleukemia (Phase 1)
Proctitis (Phase 2)
Prostatic Neoplasms (Phase 4)
Proteinuria (Phase 2)
Pruritus (Phase 2)
Psychomotor Agitation (Phase 4)
Pterygium (Phase 4)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Radiation Injuries (Phase 2)
Radiodermatitis (Phase 2)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 4)
Remission, Spontaneous (Phase 2)
Renal Insufficiency, Chronic (Phase 4)
Respiratory Distress Syndrome (Phase 1)
Respiratory Distress Syndrome, Newborn (Phase 1)
Retinal Diseases (Phase 1)
Retinal Dystrophies (Phase 2)
Retinal Vein Occlusion (Phase 4)
Retinitis (Phase 2)
Retinitis Pigmentosa (Phase 2)
Retinoblastoma (Phase 4)
Salivary Gland Diseases (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Sepsis (Phase 4)
Sex Cord-Gonadal Stromal Tumors (Phase 3)
Shoulder Pain (Phase 4)
Sinusitis (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Spinal Cord Injuries (Phase 2)
Spinal Diseases (Phase 3)
Spondylarthritis (Phase 4)
Spondylarthropathies (Phase 4)
Spondylitis (Phase 4)
Spondylitis, Ankylosing (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 4)
Stomatitis (Phase 4)
Stroke (Phase 4)
Syndrome (Phase 4)
Tendinopathy (Phase 4)
Thrombocytopenia (Phase 3)
Thrombosis (Phase 3)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Diseases (Phase 2)
Tooth, Impacted (Phase 1)
Toxemia (Phase 4)
Triple Negative Breast Neoplasms (Phase 3)
Ulcer (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Urologic Diseases (Phase 4)
Uterine Cervical Neoplasms (Phase 3)
Uveitis (Phase 2)
Vaginitis (Phase 1)
Vascular Diseases (Phase 3)
Venous Thrombosis (Phase 3)
Virus Diseases (Phase 2)
Vomiting (Phase 3)
Wounds and Injuries (Phase 2)